SMG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Scotts Miracle-Gro Co (SMG) is not a strong buy at the moment for a beginner investor with a long-term focus. While there are some positive indicators, such as improving financial metrics and a neutral technical setup, the lack of significant positive catalysts, mixed analyst sentiment, and legal uncertainties make it prudent to hold off on immediate investment.
The MACD is positive and expanding, indicating mild bullish momentum. RSI is neutral at 50.025, showing no clear overbought or oversold conditions. Moving averages are converging, suggesting indecision in the market. The stock is trading near its pivot level of 62.599, with key resistance at 65.326 and support at 59.872.
Improved gross margin (+3.59% YoY) and EPS (+78.51% YoY) in Q1 2026, indicating some operational improvements. Analysts like Stifel maintain a Buy rating with a higher price target of $79, citing underappreciated growth potential.
Legal investigations into fiduciary duties may harm shareholder confidence. Analysts like JPMorgan have downgraded the stock due to rising raw material costs and earnings growth uncertainties. Hedge funds and insiders show no significant trading activity, indicating a lack of strong conviction.
In Q1 2026, revenue dropped by -3.33% YoY to $354.4M, but net income improved significantly, reducing losses by 79.86% YoY to -$125M. EPS also improved by 78.51% YoY to -2.16, and gross margin increased to 25.4%. While these improvements are notable, the company is still operating at a net loss.
Analyst sentiment is mixed. Wells Fargo maintains an Overweight rating but lowered the price target to $72 from $75, citing inflationary pressures. JPMorgan downgraded the stock to Neutral with a reduced price target of $67, citing raw material cost concerns. Stifel remains bullish with a Buy rating and a price target of $79, citing underappreciated growth potential.
